Rebecca L. Morgan

Active 1978–2025

Also published as
Rebecca L Morgan
127
Papers
21,904
Citations
65
h-index
117
i10-index

Citations

Citations per year for Rebecca L. Morgan1967: 1 citations1979: 1 citations1980: 2 citations1981: 2 citations1982: 3 citations1983: 3 citations1984: 1 citations1985: 1 citations1986: 1 citations1987: 3 citations1988: 1 citations1991: 2 citations1993: 1 citations1994: 1 citations1997: 1 citations2000: 1 citations2001: 2 citations2003: 2 citations2004: 2 citations2006: 1 citations2007: 1 citations2008: 2 citations2009: 2 citations2010: 1 citations2011: 1 citations2012: 7 citations2013: 27 citations2014: 43 citations2015: 48 citations2016: 45 citations2017: 46 citations2018: 69 citations2019: 237 citations2020: 771 citations2021: 1,227 citations2022: 1,100 citations2023: 856 citations2024: 1,355 citations2025: 760 citations2026: 23 citations1968–1978: no citations, so these years are not shown1989–1990: no citations, so these years are not shown1992: no citations, so this year is not shown1995–1996: no citations, so these years are not shown1998–1999: no citations, so these years are not shown2002: no citations, so this year is not shown2005: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,538 citing papers, 19.5% of this breakdownCanada: 970 citing papers, 7.5% of this breakdownUnited Kingdom: 953 citing papers, 7.3% of this breakdownItaly: 693 citing papers, 5.3% of this breakdownChina: 571 citing papers, 4.4% of this breakdownGermany: 560 citing papers, 4.3% of this breakdownAustralia: 546 citing papers, 4.2% of this breakdownSpain: 450 citing papers, 3.5% of this breakdownNetherlands: 419 citing papers, 3.2% of this breakdownFrance: 345 citing papers, 2.7% of this breakdownSwitzerland: 344 citing papers, 2.6% of this breakdownBrazil: 255 citing papers, 2% of this breakdown
0%19.5%Other 33.5%

Fields

  • Medicine69.2%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Immunology and Microbiology4.4%
  • Health Professions4.1%
  • Psychology3.1%
  • Environmental Science2.4%
  • Other12%

Topics

  • SARS-CoV-2 and COVID-19 Research3.8%
  • COVID-19 Clinical Research Studies3.4%
  • Hepatitis C virus research2.1%
  • Venous Thromboembolism Diagnosis and Management1.8%
  • Liver Disease Diagnosis and Treatment1.6%
  • Asthma and respiratory diseases1.5%
  • Other85.8%

Coauthors

All papers

Open in search
  1. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2019 cited by 1,188

  2. Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes

    Authors: , , , - Environment International 2018 cited by 1,252

  3. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Environment International 2024 cited by 806

  4. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

    Authors: , , , , , , , , , , , , , , , - Blood Advances 2021 cited by 849

  5. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence

    Authors: , , , , , , , , , , , , - Journal of Clinical Epidemiology 2018 cited by 875

  6. GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2021 cited by 305

  7. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

    Authors: , , , , , , , , , , - MMWR Morbidity and Mortality Weekly Report 2022 cited by 420

  8. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

    Authors: , , , , , , , , , , , - MMWR Morbidity and Mortality Weekly Report 2022 cited by 344

  9. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2016 cited by 654

  10. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Satoshi Konno, Huahao Shen, Cathy Vitary, Andy Bush - European Respiratory Journal 2019 cited by 614

  11. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders

    Authors: , , , , , , - Gastroenterology 2020 cited by 396

  12. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season

    Authors: , , , , , , , - MMWR Recommendations and Reports 2022 cited by 316

  13. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew A. Rooney, Paul M. Schlosser, Lisa Schwartz, Ian Shemilt, Jean‐Éric Tarride, Kristina A. Thayer, Katya Tsaioun, Luke Vale, John F. Wambaugh, Jessica Wignall, Ashley R. Williams, Feng Xie, Yuan Zhang, Holger J. Schünemann - Journal of Clinical Epidemiology 2020 cited by 289

  14. Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

    Authors: , , , , , , , , , , - MMWR Morbidity and Mortality Weekly Report 2022 cited by 186

  15. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

    Authors: , , , , , , , , , , , , , - Blood Advances 2018 cited by 719

  16. European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea

    Authors: , , , , , , , , , , , , , , , , , , , - European Respiratory Review 2021 cited by 204

  17. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Athol U. Wells - American Journal of Respiratory and Critical Care Medicine 2022 cited by 226

  18. Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023

    Authors: , , , , , , , , , , , - MMWR Recommendations and Reports 2023 cited by 158

  19. Probiotics Reduce Mortality and Morbidity in Preterm, Low-Birth-Weight Infants: A Systematic Review and Network Meta-analysis of Randomized Trials

    Authors: , , , , , , , , , - Gastroenterology 2020 cited by 238

  20. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)

    Authors: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2022 cited by 201

  21. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)

    Authors: , , , , , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 1,069

  22. GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2021 cited by 160

  23. Probiotics, Prebiotics, Lactoferrin, and Combination Products for Prevention of Mortality and Morbidity in Preterm Infants

    Authors: , , , , , , , , , , , , , , , , , - JAMA Pediatrics 2023 cited by 82

  24. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

    Authors: , , , , , , , , , , , , , , - MMWR Morbidity and Mortality Weekly Report 2020 cited by 562